About this episode
The ability to engineer biology is not only revolutionizing how we treat illness, but the way grow food, and produce goods as well. With this ability, though, comes an awareness of how the same technology can be used for nefarious purposes. We spoke to Matt McKnight, general manager of Biosecurity of Ginkgo Bioworks, about our increasing ability to engineer biology, the potential risks that come with that, and the steps we are taking to safeguard ourselves against those risks.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Bio Report
Resetting Severe Allergies at Their Cellular Source
The Bio Report
Sep 2, 202633:17pending
Innovating ADCs with Dual Targeting and Smarter Delivery
The Bio Report
Aug 26, 202629:35pending
Targeting the Brain’s Immune System in Alzheimer’s Disease
The Bio Report
Aug 19, 202634:19pending
How Gilead Is Building Durable Oncology and Immunology Franchises
The Bio Report
Aug 12, 202638:31pending